Analyzes genomic, proteomic, Olink HT and electronic health-record data from BioPortal and biobanks. Targets drug discovery and precision medicine for diabetes, obesity and cardiovascular disease.
45 papers since 2024
›
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease
Nature Genetics, 2025
Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets
medRxiv, 2024
Circulating Metabolite Abundances Associated With Risks of Bipolar Disorder, Schizophrenia, and Depression: A Mendelian Randomization Study
Generates human cell lines, organoids, animal models, assays and GBA1 genetic, clinical and imaging data. Supports GBA1-targeted treatment development with QPN and C-OPN.
13 papers since 2024
›
Shared Pathogenic Pathways Between REM Sleep Behavior Disorder and Neurodegenerative and Psychiatric Disorders
medRxiv, 2026
Associations between neuromelanin depletion and cortical rhythmic activity in Parkinson’s disease
Brain, 2024
Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk
Analyzes ChIP-seq, RNA-seq, exome, whole-genome and single-cell data. Studies mammalian genomes, regulatory DNA, transposable elements and genome rearrangements in evolution and cancer.
50 papers since 2024
›
Pangenome graphs improve the analysis of structural variants in rare genetic diseases
Nature Communications, 2024
Epigenetic variation impacts individual differences in the transcriptional response to influenza infection
Nature Genetics, 2024
A unified framework to analyze transposable element insertion polymorphisms using graph genomes
Develops statistical methods for DNA methylation, targeted and whole-genome bisulfite sequencing, genotyping and imputation. Applies them to cancer genomics, microbiome and brain imaging data.
Studies Parkinson disease, ALS and dementias using next-generation sequencing, gene arrays and cellular models. Identifies therapeutic targets for rare movement disorders.
85 papers since 2024
›
Genomics yields biological and phenotypic insights into bipolar disorder
Nature, 2025
Genome-wide meta-analyses of restless legs syndrome yield insights into genetic architecture, disease biology and risk prediction
Nature Genetics, 2024
Lithium response in bipolar disorder is associated with focal adhesion and PI3K-Akt networks: a multi-omics replication study
Canada Excellence Research Chair, Genomic Medicine · active
“Our newly established Population Genomics and Multi-Omics lab (since 2022) is under the umbrella of McGill Canada Excellence Research Chair (CERC) in Genomic Medicine.”
Investigates genetic white matter disorders using advanced imaging, next-generation sequencing analysis and deep clinical phenotyping. Defines imaging biomarkers for hereditary spastic paraparesis and ataxias.
33 papers since 2024
›
Involvement of the Superior Cerebellar Peduncles in GAA- FGF14 Ataxia
Neurology Genetics, 2025
Delineating the pathogenic threshold and phenotypic spectrum of SCA27B: findings from a large French–Canadian cohort
Journal of Neurology, 2025
An adapted protocol to derive microglia from stem cells and its application in the study of CSF1R-related disorders
Uses patient iPSCs, mouse models and HiFi-GS sequencing. Studies POLR3-related leukodystrophy and other rare white-matter disorders with patient participants worldwide.
43 papers since 2024
›
Newborn screening in metachromatic leukodystrophy – European consensus-based recommendations on clinical management
European Journal of Paediatric Neurology, 2024
The use of a SOX10 reporter toward ameliorating oligodendrocyte lineage differentiation from human induced pluripotent stem cells
Glia, 2024
POLR3B is associated with a developmental and epileptic encephalopathy with myoclonic‐atonic seizures and ataxia
Funded by Canada First Research Excellence Fund, NIH +12 more
›
Fonds de Recherche du Québec en Santé, Chercheur de Mérite Award · 2025-2029
“Chercheur de Mérite Award from the FRQS (2025-2029)”
Canada First Research Excellence Fund, D2R | DNA to RNA Initiative · active
McGill's DNA to RNA initiative, a Canada First Research Excellence Fund program for genomic and RNA medicine.
“Our lab has been awarded significant funding from the Canada First Research Excellence Fund awarded to the D2R | DNA to RNA Initiative at McGill University”
NIH, Long-read genome sequencing · active
“We have received $3.1 million in NIH funding in collaboration with Children's Mercy Kansas City and the University of Utah”
Runs patient-cell screening, CRISPR/Cas9 editing, mouse models and LC-MSMS analyses. Studies peroxisomal disorders and therapies using natural-history and biobank data.
15 papers since 2024
›
Clinical Characteristics of Arginase 1 Deficiency: Natural History Insights From International Clinical Trials
Journal of Inherited Metabolic Disease, 2026
Spatial characterization of RPE structure and lipids in the PEX1-p.Gly844Asp mouse model for Zellweger spectrum disorder
Journal of Lipid Research, 2025
Peroxisome deficiency underlies failures in hepatic immune cell development and antigen presentation in a severe Zellweger disease model
Develops 10X Genomics single-cell, Nanopore long-read and targeted sequencing workflows. Applies them to cancer, viral surveillance and screening with Cancer Research UK and McGill partners.
Funded by Genome Canada, Cancer Research UK +7 more
›
Genome Canada, GAPP: Detecting Ovarian Cancer Early · active
“Current main projects include the Genome Canada GAPP “Detecting Ovarian Cancer Early””
Cancer Research UK, Grant Challenge Program: STORMing Cancer · active
“the CRUK Grant Challenge Program “STORMing Cancer””
Eli Lilly · active
“development of spatial transcriptomics and nuclei based genomics to analyze CNS funded by Eli Lilly”
Spatial transcriptomics, Long-read sequencing, Direct RNA sequencing, Microfluidics, Ultrasensitive DNA extraction and targeted sequencing, Bioinformatics analysis, High-molecular-weight DNA extraction, WGBS
Analyzes large-scale genomic datasets from population-based cohorts using Bash, R, Python and high-performance computing clusters. Studies evolutionary variation and disease to support new therapeutics.
12 papers since 2024
›
A multi-ancestry genetic reference for the Quebec population
Nature Communications, 2026
A cost-effective sequencing method for genetic studies combining high-depth whole exome and low-depth whole genome
Funded by Canada Excellence Research Chair Program
›
Canada Excellence Research Chair Program, CERC in genomic medicine · active
“I lead a population genomics research group within a mission-oriented multidisciplinary Canada Excellence Research Chair (CERC) program covering all facets of genomic medicine.”
rMCMC Gibbs sampler, Phenoselect three-population test, Haplotype-based methods, Standard association testing, Population-genetic analysis of recombination, selection, founder effect and admixture
Combines in-silico analysis of genetic epidemiology, rare-disease and pharma databases with functional genomics and clinical investigations. Builds genomic-medicine infrastructure with McGill Genome Centre and BIO-PORTAL.
9 papers since 2024
›
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease
Nature Genetics, 2025
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality
Nature Communications, 2024
Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets
Combines in-silico analysis of genetic epidemiology, rare-disease and pharma databases with functional genomics and clinical investigations. Builds genomic-medicine infrastructure with McGill Genome Centre and BIO-PORTAL.
9 papers since 2024
›
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease
Nature Genetics, 2025
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality
Nature Communications, 2024
Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets
Generates and analyzes cancer genomic, epigenomic and transcriptomic profiles using NGS, single-cell and spatial omics. Studies renal-cell carcinoma with the McGill/MUHC RCC biobank.
28 papers since 2024
›
Immune cell infiltration into brain tumor microenvironment is mediated by Rab27-regulated vascular wall integrity
Science Advances, 2025
Mesenchymal glioma stem cells trigger vasectasia—distinct neovascularization process stimulated by extracellular vesicles carrying EGFR
Nature Communications, 2024
Contribution of genetic variants in the development of familial premature coronary artery disease in a cohort of cardiac patients
Studies neurodevelopmental disorders using whole-exome and novel sequencing technologies. Identifies genes behind brain malformations and epilepsy to improve care and develop targeted treatments.
36 papers since 2024
›
Regulation of stress granule formation in human oligodendrocytes
Nature Communications, 2024
Defining the Genetic Landscape of Congenital Mirror Movements in 80 Affected Individuals
Movement Disorders, 2024
Utility of genetic testing in the pre-surgical evaluation of children with drug-resistant epilepsy
Develops statistical and machine-learning methods for spatial transcriptomics, single-cell RNA-seq and spatial metabolomics data. Uses them for disease characterization, biomarker discovery and precision medicine.
28 papers since 2024
›
The association between statin use, genetic variation, and prostate cancer risk
Prostate Cancer and Prostatic Diseases, 2025
SpaTM: topic models for inferring spatially informed transcriptional programs
Briefings in Bioinformatics, 2025
Exploring the diagnostic accuracy of an HIV self-test optimized by a digital app-based solution: Results from a secondary data analysis of a field trial in South Africa
Provides customized bioinformatics analysis and software for scRNA-seq, Visium spatial transcriptomics, WGS/WES, PacBio Hi-Fi and epigenomic data. Supports PCGL, HostSeq, cancer and microbiome genomics projects.
50 papers since 2024
›
Pangenome graphs improve the analysis of structural variants in rare genetic diseases
Nature Communications, 2024
Epigenetic variation impacts individual differences in the transcriptional response to influenza infection
Nature Genetics, 2024
A unified framework to analyze transposable element insertion polymorphisms using graph genomes
Provides bioinformatics analysis, software development and HPC services for WGS, RNA-seq, ChIP-Seq and HiC data. Supports the McGill Genome Centre and life-science researchers.
50 papers since 2024
›
Pangenome graphs improve the analysis of structural variants in rare genetic diseases
Nature Communications, 2024
Epigenetic variation impacts individual differences in the transcriptional response to influenza infection
Nature Genetics, 2024
A unified framework to analyze transposable element insertion polymorphisms using graph genomes
Studies biomarkers, histopathology, genetics and translational genomics in cardiovascular research. Focuses on vascular, cardiac and complex heart health.
Studies legal and policy issues in genomic data sharing, RNA-based precision medicine and biobanking. Works with international partners on responsible innovation and health equity.
52 papers since 2024
›
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities
Cancers, 2024
Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey
Palliative Medicine, 2024
The advent of forensic DNA databases: It’s time to agree on some international governance principles!
Studies ethical, legal and policy issues around omics, RNA-based precision medicine, gene therapies and artificial intelligence. Works with local, national and international partners.
52 papers since 2024
›
Implementing Multifactorial Risk Assessment with Polygenic Risk Scores for Personalized Breast Cancer Screening in the Population Setting: Challenges and Opportunities
Cancers, 2024
Social acceptability of psilocybin-assisted therapy for existential distress at the end of life: A population-based survey
Palliative Medicine, 2024
The advent of forensic DNA databases: It’s time to agree on some international governance principles!
Combines in-silico analysis of genetic epidemiology, rare-disease and pharma databases with functional genomics and clinical investigations. Builds genomic-medicine infrastructure with McGill Genome Centre and BIO-PORTAL.
9 papers since 2024
›
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease
Nature Genetics, 2025
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality
Nature Communications, 2024
Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets
Studies muscle stem cells using molecular and cell biology plus murine satellite-cell differentiation assays. Models Duchenne muscular dystrophy and rhabdomyosarcoma for regenerative medicine.
9 papers since 2024
›
Muscle stem cells in Duchenne muscular dystrophy exhibit molecular impairments and altered cell fate trajectories impacting regenerative capacity
Murine satellite-cell isolation and ex vivo differentiation, Primary myoblast differentiation assay
Techniques
Biochemistry, molecular and cell biology, Duchenne muscular dystrophy and rhabdomyosarcoma disease models, Automated quantification of subcellular particles, Autophagy monitoring in neural stem and progenitor cells
Develops AI methods for scATAC-seq, spatial transcriptomics, single-cell multi-omics and EHR data. Applies them to population genetics, clinical phenotyping and healthcare.
“We are hiring postdocs, visiting scholars, and McGill undergraduate or graduate students interested in machine learning, computational biology or statistical genetics.”
Performs whole exome sequencing and analyzes tumour sequencing data. Studies hereditary cancer predisposition involving DICER1, SMARCA4 and breast cancer families.
126 papers since 2024
›
MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations
JAMA Oncology, 2024
Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study
The Lancet Oncology, 2024
Bilateral Oophorectomy and All-Cause Mortality in Women With BRCA1 and BRCA2 Sequence Variations
Runs Hologic Discovery dual-energy X-ray absorptiometry, Stratec XCT-2000 peripheral quantitative computed tomography and gene sequence analysis. Studies osteogenesis imperfecta and pediatric metabolic bone disorders.
45 papers since 2024
›
The IMPACT survey: a mixed methods study to understand the experience of children, adolescents and adults with osteogenesis imperfecta and their caregivers
Orphanet Journal of Rare Diseases, 2024
The IMPACT Survey: the economic impact of osteogenesis imperfecta in adults
Orphanet Journal of Rare Diseases, 2024
Skeletal and Non-skeletal Phenotypes in Children with Osteogenesis Imperfecta
Develops mathematical and statistical tools for genetic datasets, genomic cohorts and genealogical records. Studies population variation, human evolution, genetic risk and disease.
12 papers since 2024
›
Toward whole-genome inference of polygenic scores with fast and memory-efficient algorithms
The American Journal of Human Genetics, 2025
Towards whole-genome inference of polygenic scores with fast and memory-efficient algorithms
bioRxiv (Cold Spring Harbor Laboratory), 2025
Accountability for Reasonableness as a Framework for the Promotion of Fair and Equitable Research
Studies kidney and urinary-tract disease using mouse models, cell lines, single-cell RNA-sequencing, and UK Biobank data. Works with patients on genetic testing and trials.
9 papers since 2024
›
Mouse nephron formation is impaired by moderate dose arsenical exposure
Toxicology and Applied Pharmacology, 2025
Odd-skipped family members have conserved roles in segmentation, appendage, excretory system and gut development in bilaterian animals
Differentiation, 2025
A Nuclear Magnetic Resonance (NMR)- and Mass Spectrometry (MS)-Based Saturation Kinetics Model of a Bryophyllum pinnatum Decoction as a Treatment for Kidney Stones
Integrates molecular, clinical, lifestyle and environmental data with genomics, proteomics and artificial intelligence. Studies hEDS and HSD to identify subtypes, biomarkers and genotype-phenotype associations.
9 papers since 2024
›
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease
Nature Genetics, 2025
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality
Nature Communications, 2024
Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets
Développe des méthodes bioinformatiques sur données génomiques, séquençage et généalogies BALSAC. Étudie les maladies neuropsychiatriques et la génétique des populations québécoises.
23 papers since 2024
›
Rare variants and founder effect in the Beauce region of Quebec
Communications Biology, 2025
SF3B1 mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia
Science Advances, 2024
KBTBD4-mediated reduction of MYC is critical for hematopoietic stem cell expansion upon UM171 treatment
Runs genome-wide CRISPR/Cas screens, organoid and xenograft models, and analyzes human patient datasets. Develops metastatic-cancer therapies and precision oncology strategies.
8 papers since 2024
›
Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs
npj Precision Oncology, 2024
Genome-wide in vivo CRISPR screen identifies TGFβ3 as actionable biomarker of palbociclib resistance in triple negative breast cancer
Molecular Cancer, 2024
Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis
Studies mitochondrial dynamics, mitochondrial-derived vesicles and SUMOylation with biochemical, imaging, proteomic and lipidomic approaches. Applies findings to Parkinson’s disease, immunity and metabolism.
29 papers since 2024
›
Recommendations for mitochondria transfer and transplantation nomenclature and characterization
Nature Metabolism, 2025
Mitochondrial-derived vesicles in metabolism, disease, and aging
Cell Metabolism, 2024
Modeling Parkinson’s disease pathology in human dopaminergic neurons by sequential exposure to α-synuclein fibrils and proinflammatory cytokines
Combines in-silico analysis of genetic epidemiology, rare-disease and pharma databases with functional genomics and clinical investigations. Builds genomic-medicine infrastructure with McGill Genome Centre and BIO-PORTAL.
9 papers since 2024
›
Integrative proteogenomic analysis identifies COL6A3-derived endotrophin as a mediator of the effect of obesity on coronary artery disease
Nature Genetics, 2025
Development of a long noncoding RNA-based machine learning model to predict COVID-19 in-hospital mortality
Nature Communications, 2024
Multi-ancestry proteome-phenome-wide Mendelian randomization offers a comprehensive protein-disease atlas and potential therapeutic targets
Rosenblatt Laboratory (The Hess B. and Diane Finestone Laboratory in Memory of Jacob and Jenny Finestone)mcgill.ca/rosenblatt-lab
Wet lab~4 people
Studies vitamin B12 metabolism using patient-derived fibroblasts, cancer cell lines and next-generation sequencing. Develops diagnostic assays and treatments for inherited cobalamin disorders.
17 papers since 2024
›
A non-enzymatic role of Nudix hydrolase 5 in repressing purine de novo synthesis
Science, 2025
Differential utilization of vitamin B12-dependent and independent pathways for propionate metabolism across human cells
Journal of Biological Chemistry, 2024
The MMACHC variant c.158T>C: Mild clinical and biochemical phenotypes and marked hydroxocobalamin response in cblC patients
Investigator + Industry Trials Management Team (I2T)cru.mcgill.ca/i2t
~3 people
Manages neurological clinical trials through design, regulatory submissions, study start-up, monitoring and electronic data capture. Supports academic investigators and industry partners at The Neuro.
4 papers since 2024
›
Cell-free miRNAs are pharmacodynamic biomarkers for enhanced DICER activity by enoxacin in human patients with ALS
Molecular Therapy, 2026
Dysregulated Expression of Inflammasome and Extracellular Matrix Genes in C9orf72 -ALS/FTD Microglia
ASN NEURO, 2025
Cell free miRNAs are pharmacodynamic biomarkers for enhanced Dicer activity by Enoxacin in human patients with Amyotrophic lateral sclerosis
Studies placental, craniofacial and liver morphogenesis using CRISPR/Cas9-generated mouse models. Investigates congenital malformations and human hereditary disease.
1 paper since 2024
›
eLife Assessment: PRMT1-SFPQ regulates intron retention to control matrix gene expression during craniofacial development
Studies RNA-binding proteins and translational control in Drosophila melanogaster. Uses Drosophila to investigate germ-cell specification, embryonic patterning and oogenesis.
5 papers since 2024
›
Pushing the boundaries of rare disease diagnostics with the help of the first Undiagnosed Hackathon
Nature Genetics, 2024
An EpCAM/Trop2 mechanostat differentially regulates collective behaviour of human carcinoma cells
The EMBO Journal, 2024
Model matchmaking via the Solve-RD Rare Disease Models & Mechanisms Network (RDMM-Europe)